education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Infusan-D5
Infusan-D5
glucose
Manufacturer:
Sanbe
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Per 1,000 mL
Glucose anhydrate 50 g. Osmolarity: 278 mOsm. Energy: 200 kCal
Indications/Uses
Fluid & caloric replacement. Diluent for IV drip drug.
Dosage/Direction for Use
Adult
500 mL slow IV.
Contraindications
Glucose-galactose malabsorption syndrome, diabetic coma.
Special Precautions
Slow infusion rate, monitor blood & urine glucose. Discontinue in case thrombosis occurs. Patients on corticosteroids or corticotropin.
Adverse Reactions
Febrile response, infection or tissue necrosis at the inj site, venous thrombosis or phlebitis from extending from the inj site, hypernatremia.
View
ADR Reporting Link
Drug Interactions
Corticosteroids or corticotropin; vit B complex.
MIMS Class
Intravenous & Other Sterile Solutions
ATC Classification
B05BA03 - carbohydrates ; Belongs to the class of solutions for parenteral nutrition used in I.V. solutions.
Regulatory Classification
K
Presentation/Packing
Form
Infusan-D5 infusion 50 g/1000 mL
Packing/Price
(Double port) 500 mL x 1's (Rp22,200/kantung infus); (Single port) 500 mL x 1's (Rp20,650/kantung infus); (Softbag) 100 mL x 1's (Rp19,750/kantung infus)
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk